Dao Wang to Pandemics
This is a "connection" page, showing publications Dao Wang has written about Pandemics.
Connection Strength
0.099
-
Endothelial dysfunction in COVID-19 calls for immediate attention: the emerging roles of the endothelium in inflammation caused by SARS-CoV-2. Front Med. 2021 Aug; 15(4):638-643.
Score: 0.008
-
Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients. J Mol Cell Cardiol. 2020 10; 147:74-87.
Score: 0.008
-
Mortality and Pre-Hospitalization use of Renin-Angiotensin System Inhibitors in Hypertensive COVID-19 Patients. J Am Heart Assoc. 2020 11 03; 9(21):e017736.
Score: 0.007
-
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020 08 01; 116(10):1666-1687.
Score: 0.007
-
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacol Sin. 2020 Sep; 41(9):1167-1177.
Score: 0.007
-
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020 09; 17(9):543-558.
Score: 0.007
-
Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities. Pharmacol Ther. 2020 11; 215:107628.
Score: 0.007
-
Cardiac injuries in coronavirus disease 2019 (COVID-19). J Mol Cell Cardiol. 2020 08; 145:25-29.
Score: 0.007
-
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19. Sci China Life Sci. 2020 10; 63(10):1515-1521.
Score: 0.007
-
SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020 05; 45(3):230-232.
Score: 0.007
-
Cardiovascular molecular mechanisms of disease with COVID-19. J Mol Cell Cardiol. 2020 04; 141:107.
Score: 0.007
-
SARS-CoV-2 inflames the heart. The importance of awareness of myocardial injury in COVID-19 patients. Int J Cardiol. 2020 07 15; 311:122-123.
Score: 0.007
-
Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19. Front Med. 2020 Apr; 14(2):210-214.
Score: 0.007
-
Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients. Cell Mol Immunol. 2020 09; 17(9):992-994.
Score: 0.002